HQY
HEALTHEQUITY, INC.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 17 ▲ HealthEquity (HQY) reported strong fiscal year 2026 results with rev…
- Apr 22 ▼ 1 insider sell $1.9K at $82.81
- May 28 to May 29 ▼ 2 days of insider sells: $1.2M by 3 insiders, avg $91.20
- Jun 30 to Jul 10 ▲ 2 buys: Gilbert Cisneros bought $1,001 - $15,000, last disclosed Sep 7
- Jul 2 ▼ 1 insider sell $234.7K at $95.00
- Jul 8 ▲ 1 insider buy $2.2K at $95.06
- Jul 10 ▼ 1 insider sell $223.6K at $95.00
- Aug 24 to Aug 25 ▼ 2 days of insider sells: $809.8K by 2 insiders, avg $104.62
- Aug 27 ▲ HealthEquity reported Q2 FY2027 results with revenue of $350.7M (+8%…
- Aug 27 ▲ HealthEquity reported Q2 FY2027 revenue of $350.7M (+8% YoY) and non…
- Oct 15 ▲ 1 insider buy $9.8K at $90.33
- Nov 3 Activist stake: HealthEquity Schedules Third Quarter Earnings Release Date
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $11.9K at an average $91.16. 5 insiders sold $2.5M. Price is 15% above their cost.
- InstitutionsBULLISH
Q3 2026: 30 added (1 new), 13 trimmed or exited. Largest new: Uss Investment Management $20.4M.
- AnalystsBULLISH
18 of 20 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest −7.9% to 5.48M shares. 7.5 days to cover, ≈6.6% of shares.
- TrendUPTREND
9% above its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | $133.9M |
| WESTFIELD CAPITAL MANAGEMENT CO LP | DOUBLED | $127.1M |
| Swedbank AB | ADD | $124.1M |
| FMR LLC | TRIM | $101.9M |
| Artisan Partners Limited Partnership | DOUBLED | $90.8M |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | ADD | $23.6M |
| BARCLAYS PLC | DOUBLED | $22.0M |
| USS Investment Management Ltd | NEW | $20.4M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
20 analystsPrice is below the lowest target. Median implies +18%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 21, 2026 | BMO Capital MAINTAIN | Outperform |
| Sep 18, 2026 | Barclays MAINTAIN | Overweight |
| Aug 31, 2026 | Deutsche Bank MAINTAIN | Buy |
| Aug 28, 2026 | BTIG REITERATE | Buy |
| Jul 24, 2026 | BTIG MAINTAIN | Buy |
| Jun 3, 2026 | RBC Capital REITERATE | Outperform |
Washington
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Rajasekar Sunil EVP Chief Prod & Strat Officer Oct 15, 2026 | BUY | $9.8K |
Lucania James M EVP & CFO Oct 6, 2026 | TAX W/H | $257.2K |
Cutler Scott President and CEO Oct 6, 2026 | TAX W/H | $112.1K |
Neeleman Stephen FOUNDER AND VICE CHAIRMAN Oct 6, 2026 | TAX W/H | $99.8K |
Gathright Michael Chief Customer Officer Oct 6, 2026 | TAX W/H | $60.3K |
Fiore Michael Henry Oct 6, 2026 | TAX W/H | $185.2K |
Ladd Delano EVP, General Counsel Oct 6, 2026 | TAX W/H | $98.4K |
Neeleman Stephen FOUNDER AND VICE CHAIRMAN Sep 17, 2026 | GIFT | 1,500 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
18 filings · 2 press releases · 3 bullish · 0 bearish · 2 mixed · 13 neutral- NEUTRAL PRESS RELEASENov 3, 2026
HealthEquity announced the date for its Q3 fiscal 2027 earnings release and conference call on…
Monitor the December 1 earnings release for Q3 results and any updated guidance. No immediate trading catalyst.
- NEUTRAL INST-CLUSTEROct 27, 2026
Three institutional asset managers increased their HQY positions in Q3 2026, adding a net $48.2M…
The institutional buying is one-sided but modest in scale relative to HQY's $8.6B market cap. The absence of insider buying and the stale data reduce conviction. Monitor next quarter's 13F for…
- NEUTRAL CLUSTEROct 19, 2026
Two HealthEquity insiders traded in opposite directions within a week: EVP Sunil made a token $2K…
The $2K purchase by Sunil is too small to signal conviction, and Fiore's $235K sale is routine for an EVP. No material insider signal here. Monitor next 10-Q for fundamental trends.
- NEUTRAL 8-KOct 9, 2026
HealthEquity terminated Chief Commercial Officer Michael Fiore without cause, effective October 5…
Monitor for any subsequent management restructuring or changes in commercial strategy; the redistribution of CCO responsibilities may signal organizational shifts but no immediate catalyst.
All HQY filing & press-release reports (20)
- PRESS-RELEASE reportNov 3, 2026
- INST-CLUSTER reportOct 27, 2026
- CLUSTER reportOct 19, 2026
- 8-K reportOct 9, 2026
- SC 13G/A reportOct 9, 2026
- 144 reportOct 8, 2026
- 144 reportOct 8, 2026
- 144 reportOct 8, 2026
- 144 reportOct 8, 2026
- 144 reportOct 8, 2026
- 144 reportOct 8, 2026
- 8-K reportSep 30, 2026
- 8-K reportAug 27, 2026
- PRESS-RELEASE reportAug 27, 2026
- PRESS-RELEASE reportAug 3, 2026
- 8-K reportMay 28, 2026
- CLUSTER reportJun 2, 2026
- PRESS-RELEASE reportMay 28, 2026
- 8-K reportMay 8, 2026
- PRESS-RELEASE reportMar 17, 2026